Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent
The Mayo genetic risk models offer pre-treatment and response-based prognostic tools for newly diagnosed AML treated with Ven-HMA.
The Mayo genetic risk models offer pre-treatment and response-based prognostic tools for newly diagnosed AML treated with Ven-HMA.
Canada Healthwatch | The most important health news, in one place. 🍁
Nature Medicine – This analysis of the registry database DESCAR-T of more than 3,000 pediatric and adult patients with hematological malignancies who received CAR T cell…
Vinay Prasad, MD, leads the roundtable discussion with Aaron Goodman, MD, and Al-Ola Abdallah, MD
Olaparib for BRCA mutant pancreas cancer: Should the POLO trial change clinical practice?
After brain injury, some patients are no longer able to respond to the world around them. Is this really the case?
I enjoyed Peter Thiel’s book and even more so Ryan Holiday’s book about Thiel. We also have a “mutual like” — René Girard — and…
A retired infection control nurse says she has never known a situation in hospitals where four viruses are rife at such high levels
Royal College of Emergency Medicine says it is ‘extremely concerned’ by survey on responses to emergencies like train crashes, Grenfell fire or Manchester Arena bombing
Dr. Ravi Salgia is an oncologist at City of Hope cancer center. When he and his wife and adult daughter were evacuated from their Pasadena…
Dr. Ravi Salgia is an oncologist at City of Hope cancer center. When he and his wife and adult daughter were evacuated from their Pasadena…